9 Results for "

MCF7.1

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "MCF7.1" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-10812
CAS No.: 1033739-92-2
Purity:  96.29%
Target:  

PI3K mTOR

Research Areas:  

Cancer

GNE-490, a (thienopyrimidin-2-yl)aminopyrimidine, is a potent pan-PI3K inhibitor with IC50s of 3.5 nM, 25 nM, 5.2 nM, 15 nM for  PI3Kα, PI3Kβ, PI3Kδ and PI3Kγ, respectively. GNE-490 has >200 fold selectivity for mTOR (IC50=750 nM). GNE-490 shows potent suppression efficacy profile against MCF7.1 breast cancer xenograft model .
loading...
    loading...
Cat. No.: HY-149390
CAS No.: 3052303-04-2
Research Areas:  

Cancer

TrxR1-IN-1 (Compound 5j) is a TrxR1 inhibitor (IC50: 8.8 μM). TrxR1-IN-1 has anticancer activity, with IC50s of MCF-7 (1.5 μM), HeLa (1.7 μM), BGC-823 (2.4 μM), SW-480 (2.8 μM), A549 (2.1 μM). TrxR1-IN-1 has antioxidant activity, and scavenges DPPH radical .
loading...
    loading...
Cat. No.: HY-N14603
CAS No.: 664355-12-8
Chandrananimycin A has anti-mucor activity, as well as anti-tumor cell activity such as CCL HT29, MFXF 529L, MACL McF-7 .
loading...
    loading...
Cat. No.: HY-161171
CAS No.: 2982633-16-7
Research Areas:  

Cancer

Antimalarial agent 37 (compound 33) is a selective inhibitor against Type Ⅱ kinase with antiplasmodial activity. Antimalarial agent 37 exhibited cytotoxicity and selectivity towards cancer cells HepG2 and MCF 7 .
loading...
    loading...
Cat. No.: HY-N3615
CAS No.: 585534-03-8
Confluentin can be isolated from Rhododendron dauricum. Confluentin shows weak cytotoxicity against human tumor cells (IC50: 15.05, 17.08, 18.48, and 23.01 μM for HL-60, SMMC-7712, A-549, and MCF-7) .
loading...
    loading...
Cat. No.: HY-170590
Research Areas:  

Cancer

VEGFR-2-IN-61 (Compound 7b) is an inhibitor for VEGFR-2 with an IC50 of 2.83 µM. VEGFR-2-IN-61 inhibits the proliferation of multi cancer cells (IC50 for MCF-7 is 2.12 μM). VEGFR-2-IN-61 inhibits the cell migration, induces oxidative stress and apoptosis in MCF-7 .
loading...
    loading...
Cat. No.: HY-161852
Target:  

PI3K Apoptosis

Research Areas:  

Cancer

PI3K-IN-55 (Compound 6a) is a potent inhibitor for PI3K. PI3K-IN-55 affects PI3K/Akt/p53 signaling pathway, inhibits the proliferation of cancer cells A549, Hela, HepG2, MCF-7 and HT-29, with IC50s of 1.03-6.78 μM. PI3K-IN-55 induces apoptosis in cell MCF-7 .
loading...
    loading...
Cat. No.: HY-N14604
CAS No.: 664355-13-9
Chandrananimycin B has anti-mucor activity, as well as anti-tumor cell activity such as CCL HT29, MFXF 529L, MACL McF-7 .
loading...
    loading...
Cat. No.: HY-186161
CAS No.: 1446686-55-0
Target:  

Others

Research Areas:  

Cancer

Antiproliferative agent-77 is an anticancer cell proliferation agent that exerts significant antiproliferative effects on HCT116, HepG2, H1299 and MCF-7 .
loading...
    loading...